Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: Biochem Biophys Res Commun. 2016 Jul 25;478(2):559–564. doi: 10.1016/j.bbrc.2016.07.100

Table 1.

Outline of enzyme inhibitors used in this study.

Group Inhibitors added (50 µM each)
All Inhibitors RAS inhibitors (chymostatin for chymase; lisinopril for
ACE; MLN-4760 for ACE2; and SCH39370 for neprilysin),
aminopeptidase inhibitors (amastatin and bestatin),
carboxypeptidase inhibitor (benzyl succinate) and PCMB.
No chymostatin All above inhibitors except chymostatin.
No lisinopril All above inhibitors except lisinopril.